Smartkem Reports Fourth Quarter and Full Year 2023 Financial Results
MANCHESTER, England, March 28, 2024 /PRNewswire/ -- Smartkem (OTCQB: SMTK), the developer of a new class of semiconductor polymer transistors...
Monday, January 13, 2025
Trina Solar Powers New Zealand's Largest Solar Farm with Integrated Module-Tracker Solution
KAITAIA, New Zealand, March 28, 2024 /PRNewswire/ -- Trina Solar, a global leader in smart PV and energy storage solutions,...
Fueling Cybersecurity Innovation: Vivek Ramachandran Takes on Black Hat Arsenal Review Board Role with a Mission to Mentor and Motivate the Next Generation
SINGAPORE, March 28, 2024 /PRNewswire/ -- In the field of cybersecurity, very few events command the respect that BlackHat does. Known...
Moomoo Announces the Moomoo Foundation Establishment, Hosts Financial Literacy Event with NYU's Economic Society
JERSEY CITY, N.J., March 28, 2024 /PRNewswire/ -- Moomoo, the intuitive investment and trading platform is thrilled to announce that...
Allprostar to Showcase its New Camping Series at Hong Kong Global Sources Sports & Outdoor Show 2024
XIAMEN, China, March 28, 2024 /PRNewswire/ -- Allprostar(Xiamen) Industrial Co.,Ltd has over 16 years of experience outdoor product development and...
Canadian Solar Comments on Complaint Filed by Maxeon Solar
GUELPH, ON, March 28, 2024 /PRNewswire/ -- Canadian Solar Inc. (the "Company", or "Canadian Solar") (NASDAQ: CSIQ), today issued the following...
Volvo Financial Services, JA Worldwide Expand Partnership, Bringing Financial Literacy Education to More Youth
GREENSBORO, N.C., March 28, 2024 /PRNewswire/ -- Volvo Financial Services (VFS) today announced a continuation of its partnership with JA...
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma
SHANGHAI, March 28, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today...
© 2022 Siam News Network - Thailand Business News and advertising Network. Powered by VLoss.